Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

BA-BE Studies: SOP for Ensuring Backup Power for Sample Freezers – V 2.0

Posted on By

BA-BE Studies: SOP for Ensuring Backup Power for Sample Freezers – V 2.0

Standard Operating Procedure for Ensuring Backup Power for Sample Freezers in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/126/2025
Supersedes SOP/BA-BE/126/2022
Page No. Page 1 of 8
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To define the procedure for ensuring uninterrupted power supply to freezers storing biological samples in BA/BE studies by implementing reliable backup systems to prevent sample degradation during power failures.

2. Scope

This SOP applies to all clinical and bioanalytical research facilities involved in BA/BE studies where biological samples are stored in freezers operating at -20°C and -70°C.

3. Responsibilities

  • Facility Maintenance Officer: Ensures functioning of backup power systems, including generator and UPS.
  • Bioanalytical Staff: Monitors freezer temperature and logs excursions during outages.
  • QA Officer: Verifies implementation of backup procedures and reviews logbooks.
  • Study Coordinator: Alerts facility team during outages and maintains freezer surveillance.
See also  BA-BE Studies: SOP for Labelling of Biological Samples - V 2.0

4. Accountability

The Head of Bioanalytical Facility is accountable for ensuring all critical equipment including sample freezers have uninterrupted power supply backed by validated systems.

5. Procedure

5.1 Backup Power Infrastructure

  1. All sample freezers shall be connected to an automatic power backup system comprising:
    • Online UPS (minimum 2-hour capacity)
    • Diesel Generator (DG) set with auto-start within 30 seconds
  2. Verify electrical connectivity weekly using Annexure-1: Freezer Power Backup Checklist.

5.2 Power Failure Monitoring and Response

  1. Install power failure alarm systems on all critical freezers.
  2. In the event of power failure:
    • UPS provides immediate backup
    • DG set should activate automatically
    • Facility team must verify transfer within 1 minute
  3. Record outage and system switch-over in Annexure-2: Power Failure Incident Log.

5.3 Temperature Monitoring During Power Outage

  1. Each freezer must be equipped with:
    • Digital temperature display
    • 24/7 data logger
    • Visual/audio alarm system
  2. Study staff to manually log temperatures at 15-minute intervals during outages using Annexure-3.
See also  BA-BE Studies: SOP for Clinical Documentation of Adverse Events - V 2.0

5.4 Preventive Maintenance and Testing

  1. Schedule monthly load testing of:
    • UPS battery life
    • DG fuel level and startup performance
  2. Document findings in Annexure-4: Backup System Maintenance Log.

5.5 Escalation and Sample Transfer (If Needed)

  1. If power backup fails or temperature exceeds acceptable limits:
    • Notify QA, PI, and sponsor immediately
    • Transfer samples to validated alternate freezer (pre-identified)
    • Use validated cool boxes with dry ice for temporary transport
  2. Log the transfer in Annexure-5: Emergency Sample Relocation Form.

6. Abbreviations

  • UPS: Uninterruptible Power Supply
  • DG: Diesel Generator
  • BA: Bioavailability
  • BE: Bioequivalence
  • QA: Quality Assurance
  • PI: Principal Investigator

7. Documents

  1. Freezer Power Backup Checklist – Annexure-1
  2. Power Failure Incident Log – Annexure-2
  3. Manual Temperature Monitoring Log – Annexure-3
  4. Backup System Maintenance Log – Annexure-4
  5. Emergency Sample Relocation Form – Annexure-5

8. References

  • ICH E6(R2) – Good Clinical Practice
  • 21 CFR Part 58 – GLP for Nonclinical Studies
  • WHO Guidelines for Biological Sample Handling

See also  BA-BE Studies: SOP for Developing Study Synopsis for Ethics Submission - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Freezer Power Backup Checklist

Date UPS Test Result DG Status Checked By
15/04/2025 Pass Auto-start OK Ajay Verma

Annexure-2: Power Failure Incident Log

Date Start Time End Time Freezers Affected Remarks
16/04/2025 11:32 AM 11:50 AM FZ-02, FZ-03 Backup restored within 2 min

Annexure-3: Manual Temperature Monitoring Log

Time Freezer ID Temperature (°C) Recorded By
11:35 FZ-02 -69.2 Sunita Reddy

Annexure-4: Backup System Maintenance Log

Date UPS Battery Voltage DG Test Run Status Maintained By
10/04/2025 24V Pass Rajesh Kumar

Annexure-5: Emergency Sample Relocation Form

Date From Freezer To Freezer Samples Moved Moved By
16/04/2025 FZ-02 ALT-FZ-01 96 Meena Joshi

Revision History:

Revision Date Revision No. Details Reason Approved By
10/01/2022 1.0 Initial SOP Release GCP Requirement QA Head
17/04/2025 2.0 Added UPS/DG testing and sample relocation SOP Risk Mitigation Enhancement QA Head
BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

Post navigation

Previous Post: API Manufacturing: SOP for Online Monitoring using PAT Tools – V 2.0
Next Post: Elixir Department: SOP for Preparation of Manufacturing Tank – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version